Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00607308
What this trial is testing

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 20
Early research (Phase 1)Study completedNCT02386306
What this trial is testing

Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GliaCure, Inc. 39
Not applicableLooking for participantsNCT05926011
What this trial is testing

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
REGEnLIFE SAS 108
Large-scale testing (Phase 3)UnknownNCT01282619
What this trial is testing

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shandong Luye Pharmaceutical Co., Ltd. 390
Not applicableStudy completedNCT01825330
What this trial is testing

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 131
Early research (Phase 1)Study completedNCT00397891
What this trial is testing

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 80
Large-scale testing (Phase 3)Study completedNCT01741194
What this trial is testing

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Who this might be right for
Alzheimer's Disease
Cerecin 418
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Testing effectiveness (Phase 2)Study completedNCT01453569
What this trial is testing

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive Impairment
Shanghai Greenvalley Pharmaceutical Co., Ltd. 255
Not applicableStudy completedNCT02210286
What this trial is testing

Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia

Who this might be right for
DementiaAlzheimer's Disease
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT00454870
What this trial is testing

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 80
Not applicableStudy completedNCT01746498
What this trial is testing

Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients

Who this might be right for
Alzheimer Disease
Assiut University 33
Testing effectiveness (Phase 2)Ended earlyNCT00555204
What this trial is testing

Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Abbott 337
Testing effectiveness (Phase 2)UnknownNCT04780399
What this trial is testing

Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseYangxue Qingnao PillsRandomized
Dongzhimen Hospital, Beijing 216
Large-scale testing (Phase 3)Study completedNCT00103649
What this trial is testing

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,306
Testing effectiveness (Phase 2)UnknownNCT03625401
What this trial is testing

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Early Onset
Zhejiang Hisun Pharmaceutical Co. Ltd. 55
Early research (Phase 1)Study completedNCT01795339
What this trial is testing

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

Who this might be right for
Healthy Elderly VolunteersMild-to-moderate Alzheimer's Disease Patients
AstraZeneca 47
Not applicableLooking for participantsNCT06862557
What this trial is testing

Pulsed Electromagnetic Field Treatment With Dementia Patients

Who this might be right for
Alzheimer's DiseaseLewy Body DementiaVascular Dementia
Herrick Medical LLC 48
Testing effectiveness (Phase 2)Study completedNCT01073228
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 409
Testing effectiveness (Phase 2)Study completedNCT00976118
What this trial is testing

Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AB Science 34
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation